Stille

Stille Financing Cash Flow

The Net Financing Cash Flow of Stille (STIL.ST) as of Oct 24, 2026 is 36.16 M SEK. In the previous year, Net Financing Cash Flow was 171.40 M SEK — a change of -78.90% (lower).

Financing Cash Flow

36.16 MSEK

YoY

-78.90%

Last updated:

Net Financing Cash Flow of Stille is 2025 36.16 M SEK. Net Financing Cash Flow of Stille was 2024 171.40 M SEK. It decreases by -78.90% lower compared to the previous year.

The Stille Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2018
-5.61 M SEK
Jan 1, 2019
-9.01 M SEK
Jan 1, 2020
-2.75 M SEK
Jan 1, 2021
33.22 M SEK
Jan 1, 2022
-18.54 M SEK
Jan 1, 2023
178.99 M SEK
Jan 1, 2024
171.40 M SEK
Jan 1, 2025
36.16 M SEK
The Stille Financing Cash Flow history
YEARFinancing Cash FlowYoY
36.16 MSEK-78.90%
171.40 MSEK-4.24%
178.99 MSEK-1,065.49%
-18.54 MSEK-155.81%
33.22 MSEK-1,308.77%
-2.75 MSEK-69.51%
-9.01 MSEK+60.70%
-5.61 MSEK-1.72%
-5.71 MSEK+9.14%
-5.23 MSEK+459.74%
-934,000.00SEK-51.07%
-1.91 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stille Stock analysis

What does Stille do? Stille AB generates revenue by developing and selling medical equipment through two distinct business lines. The Surgery business area focuses on handcrafted, forged surgical instruments for open surgery, particularly in cardiovascular, reconstructive, and aesthetic plastic surgery. This segment produces essential tools such as scissors, forceps, artery forceps, needle holders, and clamps for medical professionals requiring precision instruments. The second revenue stream comes from the Patient Positioning area, which manufactures specialized procedure-specific tables. These devices are designed for cardiovascular surgery as well as gynecology, urology, and urodynamic examinations. By offering tailored positioning solutions for these specific medical fields, the company supports clinical procedures that require precise patient alignment. The company's operational structure includes wholly owned subsidiaries Stille Surgical Inc. and Stille Incentive AB, which support its manufacturing and distribution efforts. In 2013, the company adjusted its portfolio by selling its Sonesta business unit to ADDvise Lab Solutions publ AB, allowing it to focus on its core surgical and positioning equipment offerings. Stille is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stille stock

Net Financing Cash Flow of Stille is 36.16 M SEK in 2025.

Net Financing Cash Flow of Stille changed from 171.40 M SEK to 36.16 M SEK, representing a -78.90% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Stille since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Stille historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Stille

All Key Metrics — Stille